UnknownNot Applicable

Outcomes of the Embryos of Different Ovarian Follicle Sizes, and the miRNA Detection in Their Blastocyst Culture

Turkey (Türkiye)55 participantsStarted 2023-06-20

Plain-language summary

In this study, it is aimed to analyze the outcomes of embryos obtained from ovarian follicle with different sizes, and identify the microRNA expression in the spent media of the blastocysts cultures.

Who can participate

Age range

20 Years – 38 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female patients aged between 20-38 who are planned to have IVF treatment * On the day of trigger before the oocyte pick-up, patients having at least 5, and 14 at most follicles exceeding 11mm * Patient having BMI below 30 Exclusion Criteria: * PCO patients * Patients having endometriosis * Patients having male factor with severe oligoazoospermia

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Oocyte grading

Timeframe: after each hyper stimulation process of the patients, when the follicle sizes are large enough to pick up which is roughly 10-15 days after the hyper stimulation has started

Day-3 Embryo Grading

Timeframe: Three days after the intracytoplasminc sperm injection(ICSI) procedure

Day-5 Embryo Grading

Timeframe: 5 days after the intracytoplasminc sperm injection(ICSI) procedure

beta hCG results of the transferred embryos

Timeframe: ten days after the embryo transfer

Trial details

NCT IDNCT05947526

SponsorAcibadem University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-10-20

Contact for this trial

NAZLI ALBAYRAK, MD

00905054111626 albayraknalzi@gmail.com

View on ClinicalTrials.gov More Embryo Quality trials